The compounds [Ph 2 PCH 2 CH 2 COO]EO x (OR) 3 - 2 x (E = Ti, Zr) were obtained by two routes: by HPPh 2 addition to the double bond of [CH 2 CHCOO]EO x ‘ (OR) 3 - 2 x ‘ and by reaction of E(OR) 4 with Ph 2 PCH 2 CH 2 COOH. The second route results in less byproducts. The sulfonate derivatives [Ph 2 PCH 2 CH 2 SO 3 ]EO x (OR) 3 - 2 x and the hydroxamate derivatives [Ph 2 PCH 2 CH 2 ClO)N(H)O]EO x (OR) 3 - 2 x were prepared by the second route, i.e., reaction of Na[O 3 SCH 2 CH 2 PPh 2 ] or K[ON(H)C(O)CH 2 CH 2 PPh 2 ] with E(OR) 4 . Reaction of (CO) 5 W(OEt 2 ) with the compounds Ph 2 P−X−E(OR) 3 gave the phosphine complexes W(CO) 5 [PPh 2 −X−E(OR) 3 ] in each case. The bond between the titanium or zirconium atom and the PPh 2 -substituted bidentate ligand is hydrolytically stable. The X-ray structure analysis of Zr(OPr)(O 3 SMe) 3 showed the compound to have a chain structure with two bridging and one chelating sulfonate group per zirconium atom.
No takes yet. Share an insight, caveat, or question.
Lorenz et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: